The long-term stasis of blood in the liver, known as chronic liver congestion, can lead to a range of diseases, some of which ...

In this webinar, Jorge López, MSc, Flow Cytometry and Hematology Specialist, will discuss the implementation of PIDOT within a Next Generation Flow™ cytometry framework as a sta ...

Discover how modern cardiovascular services protect your heart. Learn about expert cardiology care teams and preventative ...

Definium Therapeutics' lead asset, DT120 ODT, has received FDA Breakthrough Therapy Designation for generalized anxiety disorder. The company is preparing for potential commercialization by building ...

Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through a specific signaling pathway in liver sinusoidal endothelial cells - key cells ...

In the UK, wide‑ranging reforms coming into force on 28 April 2026 are designed to streamline approvals, embed a more ...

A small but growing body of evidence suggests that a minimally invasive surgical procedure called lymphovenous anastomosis ...

Revolutionary Liquid Pump Product for Optimal Performance Tempe, Aruba - February 25, 2026 / Performance Supplements / ...

A new clinical trial has found that a multi-ingredient longevity supplement may help improve key markers of vascular aging, such as arterial flexibility and healthy blood pressure support.

New research explores if lymphovenous bypass surgery, typically used in plastic surgery, can treat Alzheimer's by flushing neurotoxins from the brain.

Peetz announced 2026 net product sales guidance of $630 million to $650 million. He emphasized pipeline progress, noting the approval of CTEXLI for CTX, a tablet formulation of LIVMARLI, and ...